Tysabri Prices, Coupons, Copay Cards & Patient Assistance
Tysabri (natalizumab) is a member of the selective immunosuppressants drug class and is commonly used for Crohn's Disease - Maintenance, and Multiple Sclerosis.
The cost for Tysabri (300 mg/15 mL) intravenous concentrate is around $9,124 for a supply of 15 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Tysabri prices
Intravenous Concentrate
300 mg/15 mL
Tysabri intravenous concentrate
from $9,124.18
for 15 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 15 milliliters | $608.28 | $9,124.18 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Tysabri Coupons, Copay Cards and Rebates
Tysabri offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Tysabri Biogen Copay Program
Eligible commercially insured patients may have their medication cost lowered to as little as $0.
- Applies to:
- Tysabri
- Number of uses:
- per prescription per year
Form more information phone: 800-456-2255 or Visit website
Tysabri Infusion Copay Assistance Program
Eligible commercially insured patients may save $250 per infusion.
- Applies to:
- Tysabri
- Number of uses:
- per infusion
Form more information phone: 800-456-2255 or Visit website
Patient Assistance & Copay Programs for Tysabri
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Tysabri (natalizumab) Vial; Single-Use
More information please phone: 866-316-7263 Visit Website
Provider: Biogen Support Services
Eligibility requirements:- Determined case by case
- Based on FPL
- Relapsing form of MS
- The patient must also be residing in the US.
- Call for most recent medications as the list is subject to change.
- Tysabri (natalizumab) Vial; Single-Use
More information please phone: 800-456-2255 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Cimzia
Cimzia injection (certolizumab pegol) is used to treat Crohn's disease, rheumatoid arthritis ...
Infliximab
Infliximab infusion (brand names Avsola, Inflectra, Remicade, and others) reduces inflammation and ...
Adalimumab
Adalimumab is used to treat plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid ...
Azathioprine
Azathioprine systemic is used for atopic dermatitis, autoimmune hepatitis, behcet's disease ...
Mesalamine
Mesalamine is used to treat mild to moderate ulcerative colitis and prevent the symptoms of ...
More about Tysabri (natalizumab)
- Check interactions
- Compare alternatives
- Reviews (98)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
